Trichoderma infection of cerebrospinal fluid shunt device in a non immunocompromised patient;Infection à trichoderma sur valve de dérivation du liquide céphalorachidien chez un patient non immunodéprimé

Journal de Mycologie Medicale

Volumn 14, Issue 1, 2004, Pages 49-51

  Piens, M A ^a,d   Celard M ^b   De Monbrison, F ^a   Grando, J ^b   Vandenesch, F ^b   Mottolese, C ^c   Picot, S ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c Service de Neurochirurgie   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

Antifungal drugs; Cerebrospinal fluid shunt device; Infection; Trichoderma

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID SHUNTING; CONGENITAL HYDROCEPHALUS; FUNGUS CULTURE; HUMAN; INFECTIOUS COMPLICATION; MALE; NONHUMAN; SHUNT INFECTION; TREATMENT OUTCOME; TRICHODERMA;

CANDIDA; FUNGI; HYPOCREA JECORINA; TRICHODERMA;

EID: 1842813386     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Arisan-Atac I, Heidenreich E, Kubicek CP. Randomly amplified polymorphic DNA fingerprinting identifies subgroups of Trichoderma viride and other Trichoderma spp. capable of chestnut blight biocontrol. FEMS Microbiol Letters 1995;126:249-56.
2. Bayston R. Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections. Neurosurg Clin N Am 2001;12:703-8.
3. Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002;35:1360-7.
4. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875-80.
5. Espinel-Ingrof A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001;39:954-8.
6. Halpin DMG, Graneek BJ, Turner-Warwick M, Newman-Taylor AJ. Extrinsic allergic alveolitis and astlima in a sawmill worker: case report and review of the literature. Occup Environ Med 1994;51:160-4.
7. Kuhls K, Lieckfeldt E, Börner T, Guého E. Molecular reidentification of human pathogenic Trichoderma isolates as Trichoderma longibrachiatum and Trichoderma citrinoviride. Med Mycol 1999;37:25-33.
8. Montero A, Romero J, Vargas JA, Regueiro CA, Sanchez-Aloz G, de Prados F, et al. Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta Neurochir 2000;142:67-74.
9. Mottolese C, Grando J, Convert J, Abdoulrahman M, Lelièvre H, Vandenesch F, et al. Zero rate of shunt infection in the first postoperative year in children - dream or reality? Childs nerv Syst 2000;16:210-2.
10. Soonthornpoct P, Trevathan LE, Gonzales MS, Tomaso-Peterson M. Fungal occurrence, disease incidence and severity, and yield of maize symptomatic for seedling disease in Mississipi. Mycopathologia 2000;150:39-46.